Japanese version of "Mounjaro weight loss injection Tirzepatide" science popularization post

① Dual receptor agonism, potent appetite suppression

• GLP-1 actionDirectly acts on the brain's satiety center, significantly enhancing the feeling of fullness and effectively reducing hunger and food intake.
• GIP functionco-regulate energy expenditure, improve insulin sensitivity, and further reduce fat storage.

✅ Results: After use, you’ll notice a marked increase in feelings of fullness, leading to a natural reduction in food intake; in particular, intense cravings for high-sugar and high-fat foods will be significantly reduced.

② Delay gastric emptying and maintain stable blood sugar

• Moderateslow gastric emptyingwhich keeps food in the stomach longer and prolongs the state of fullness.
• ValidStabilize postprandial blood glucose fluctuations, to prevent sudden binge eating and intense hunger caused by sharp drops in blood sugar.

✅ Result: After eating, you can maintain a stable state for a long time and are less likely to feel hungry frequently.

③ Increase fat burning and promote deep lipolysis

• Combined action of GLP-1 and GIPAccelerate fat metabolism and reduce fat accumulation, specifically targeting visceral fat and stubborn subcutaneous fat.
• Increasing energy expenditure helps boost overall basal metabolism.

✅ Result: Not only was it achieved, but...Substantial reduction of body fatwhile significantly improving blood sugar and metabolic indicators, thereby reducing the risk of related chronic diseases.

• non-diabetic obese patients(BMI ≥ 30):
  • UseAt the highest dose (15 mg), the average weight loss over 72 weeks reached 20.91 TP3T.(approximately 22.5 kg).
  • The proportion of participants whose weight loss reached or exceeded 15% was as high as 89%.
• Horizontal comparisonCompared to traditional single-receptor drugs (such as semaglutide Wegovy 2.4mg), tirzepatide demonstrates more potent and sustained weight loss performance.

• starting dose：2.5mg, administered as a subcutaneous injection once weekly (abdomen, thigh, or back of the upper arm may be chosen).
• dose titration(Evaluated and adjusted every 4 weeks):
  👉 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg (maximum dose)。
• 💡 Important ReminderMedication must be taken gradually under the guidance of a professional physician. Do not increase the dosage without authorization to avoid severe gastrointestinal discomfort.

• common mild reactions(Most gradually develop tolerance over time): nausea (most common), mild diarrhea, loss of appetite, occasional bloating or constipation.
• Rare matters requiring attentionHypoglycemia (commonly seen in those taking combination glucose-lowering medications), very rare inflammatory reactions; animal studies have suggested a risk of thyroid C-cell tumors (not yet confirmed in human studies).

✅ Recommendations for Clinical Remission:

1. Avoid overeating, adopt a light diet, and reduce the intake of high-fat and high-sugar foods.
2. During each dose titration period,Drink more water and practice eating small, frequent meals.Give your body plenty of time to adapt.

• The Japanese version of tirzepatide (Mounjaro) is not only a powerful tool for blood sugar control in type 2 diabetes patients, but has also set a brand-new benchmark in the field of modern scientific weight management.
• By combining a balanced diet and a healthy lifestyle, it can help patients achieve safe, stable, and long-lasting weight loss goals.